<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 156 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page155.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=156">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 156 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 156</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=156"><img src="../thumb/156.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.4.2                                                 2020-04 / 125
       Dosage: Hypertens: 100 mg dly.as sngl./div. dos.  & pulm.complicat.in neonates in post natal peroid, hepat./ren.im-  Contraindications: 2nd & 3rd degree heart block, CCF, verapamil
       Ang.pect: 100 mg dly.as sngl./div.dos.  pairm., elderly, discont.if bradycard./hypotens.occur, exacerbat.of   therapy, metabol.acidos., aft. prolong.fast.
       Contraindications: Metabol.acidos., sinus bradycard., part.heart   ang.pect. aft. abrupt discont.in ischaem.heart dis.pts., physic. activ.  Side effects: Cold extremit., insomn., CNS eff., dry mouth &/
       block, phaeochromocyt. without a-adrenerg.block.ther., verapamil   limit.dur.withdr.per., decompens. cirrhos., sex.impot., HF foll.MI to   stomatit., neuropsych.disords., CCF, bradycard., allerg.reacts., skin
       ther., periph. vasc.dis., Raynauds.  be controll.bef. treatm.  rash, alopec., weight gain, bld.disords., dry eyes, trans.hear. loss,
       Side effects: GI disturbs., CNS eff., CCF, bradycard., heart block,   Drug interactions: Poss.prolong hypoglycaem. respons. to insul.,   paraesthes., imp.sex.funct., impot., vis. disturbs., fluid retent., bron-
       hypotens., cold extremit., Raynauds, paraesthes., bronchoconstrict.,   life-threat.eff.with concom. hypoglycaem.agents, phenothiazines,   choconstrict., hypotens., paradox.hypertens., metabol.disturbs.,
       bld. disords., skin rash, fluid retent., weight gain, musc. cramps, dry   class 1 anti-arrhythm., digital.glycosid.incr.AV conduct.time, exagger.  myopathies, exacerb.periph.vasc.dis., hypoglycaem., skelet.musc.
       mouth, impot., floppy inft.syndr.if giv. prior/dur.labour.  neg.inotrop.eff.of Ca chann.block.partic.in pts.with impair.ventricul.  weakn., GI disturbs., sev. periph.vasc.dis., periph.gangrene, floppy
       Special precautions: Bronch.asthma & other obstruct.airway dis.,   funct.&/SA/AV conduct. abnormalit., incr.hypotens.risk with nifedi-  inft. syndr. (giv.prior/dur.labour).
       digitalisat.of CCF pts., peri-op period, masks hyperthyroid., clonidine   pine, poss. eff.counteract.by sympathomimet., plasma conc. of lig-  Special precautions: Asthma, bronchit., chron. resp.dis., bradycard.
       transf., grad. withdr., ren.impairm.  nocaine incr.with IV admin., may incr. plasma lev.with cimetidine &   (&lt; 50 beats/min.), periph vasc. dis., Raynaud’s phenomenon, elderly,
       Drug interactions: Eff.dimin.by ß adrenocept. stimul., hypotens.eff.  hydralazine, alcoh. incr. plasma lev., rebound hypertens.exacerbat.   ren. dysfunct., peri-op period, norm.tachycard. respons. to hypovol-
       revers.& periph. vasoconstrict. eff.enhanc.by a-adrenocept.stimul.   poss. foll.clonidine withdr., concom.ergotamine, dihydroergotamine   aem./bld.loss poss.obscured dur./aft surg., clonidine transf., excret.
       (eg.adrenal.& nor-adrenal), concom.hypoglycaem. agents, pheno-  /relat.cmpds., antihypertens. eff.reduc.by prostaglan.synthetase in-  into breast milk, anaethes., masks hyperthyroid., digitalisat.of pts like-
       thiaz., various anti-arrythm.agents can be life threat., eff.of myo-  hibit., incr. plasma lev. of both meds.with concom. chlorpromazine,   ly to develop CCF, phaeochromocyt.req. concom. a-adrenerg.block.
       card.depress., phenytoin & meds.interfer.with Ca transport may be   attenuat.of reflex tachycard.& incr. hypotens.risk with b-blocks   ther., grad.withdr., hypoglycaem. sympts.poss.mask.in diabet.mellit.
       enhanc., effs.enhanc.by adrenerg.neurone block. agents., hypotens.  & cert.anaesthet. agents, bld.conc.of quinidine, propafenone, ri-  Drug interactions: Concom.hypoglycaem.agents, phenothiaz., vari-
       eff.enhanc.by diuret., digitalis card.effs.enhanc./dimin.  fampicin, theophylline, warfarin, thioridazine & dihydropyridine Ca   ous anti-arrythm.agents can be life threat., eff.enhanc.by adrenerg.
                                     chann.blocks.poss.aff.
       CONCOR, Merck (Biopharma Division)                         neurone block. agents., eff.antagon.by ß adrenocept.stimul., hypo-
                                                                  tens. eff.revers.& periph. vasoconstrict.eff. enhanc.by a-adrenocept.
       See Section 7.3.3             LOPRESOR, Novartis South Africa (Pty) Ltd  stimul.(eg.adrenal.& nor-adrenal), hypotens.eff.enhanc.by diuret., eff.
                                     See Section 7.3.3
       HEXA-BLOK 50 & 100, (Sandoz) Hexal [PWR]                   of myocard. depress.(lignocaine, procainamide, quinidine, phenytoin,
       Atenolol.                     PUR-BLOKA, Litha [PWR]       med.interfer.with Ca transport) may be enhanc.
       Indications: Ang.pect., hypertens.  Propranolol HCl.       TEN-BLOKA, (Aspen Pharmacare: Pharma) Pharmacare
       (S3) TABS. 27/5.2/0468, 0469.  Indications: Card.arrhythm., ang.of effort, hypertens., thyrotoxic.,   [PWR]
       806889-004: 50 mg, 30, R33,77  phaeochromocyt., migraine prophylax, contr.of essent.tremor.  Atenolol.
       806897-007: 100 mg, 30, R67,57  (S3) TABS. L/5.2/192, 193.  Indications: Ang.pect., hypertens.
       Dosage: Ang.pect: 50-100 mg dly.as sngl./div. dos.  758140-002: 10 mg, 50, R11,05  (S3) TABS. V/5.2/56, 57.
       Hypertens: Init. 50 mg dly.may incr.to 100 mg aft.a few wks.if adeq.  758140-010: 10 mg, 1 000, R221,55  786187-026: 50 mg, 30, R50,09
       response not evid.            758167-008: 40 mg, 50, R14,58  786195-010: 100 mg, 30, R73,37
       Contraindications: 2nd/3rd degr.heart block, verapamil, prolong.  758167-016: 40 mg, 250, R72,95  Dosage: Ang.pect: 100 mg dly as sngl./div.dos.
       fast., metab.acidos., CHF until control. with digital., asthma, bron-  758167-024: 40 mg, 1 000, R291,83  Hypertens: 100 mg dly as sngl.dos.
       chit., chron. resp. dis., bradycard.of less than 50/min., phaeochro-  Dosage: Take.bef.meals.  Contra-indications: Part.heart block, phaeochromocyt. without
       mocyt. without concomit.a-adrenerg. block.  Hypertens.: 40-80 mg 2 x dly.incr.to 160-320 mg dly. Not suitable   concom.a-adrenocept. block. ther., verapamil ther., bronch.asthma,
       Side effects: GI disturbs., CNS eff., bradycard., hypo-/ hypertens.,   for emerg.hypertens.treatm.  bronchit., bronchosp., chron.resp.dis., obstruct. airway dis.hist.,
       Raynaud’s phenom., bld. disords., paraesthes., sev.periph.vasc.dis.  Angina: 40 mg 2-3 x dly.incr.wkly.as req.to 120-240 mg dly.  metabol.acidos., AV block, bradycard. (&lt;50 beats/min), HF refract.
       poss. precipitat. periph.gangrene, CHF/ heart block precipitat., vis.  Card.arrythm: 30-160 mg dly in div.doses for long term managem.  to digital., uraem., pregn., lactat., hypoglycaem., 2  &3  degree
                                                                                           rd
                                                                                        nd
       disturbs., hear.loss., rash, bronchoconstrict.in suscept.indiv., allerg.  Temp.suppress.of thyrotoxicos.& in thyrotox. crisis: 10-  heart block, periph.vasc. dis., Raynaud’s phenom.,aft.prolong.fast.,
       reacts., metabol.disturbs., fluid retent., mass gain, alopec., myopa-  40 mg 3-4 x dly.  cardiogen.shock.
                                     Phaeochromocytoma: 60 mg dly.on 3 pre-op. days in associat.
       thies, dry eyes, stomatit., impot., musc. weakn.           Side-effects: GI disturbs., CNS eff., bradycard., hypotens., paradoxic.
       Special precautions: Clonid.transf., pregn. mothers shortly bef.  with alpha-blockade. If tumor inoperable prolong.treatm.may be giv.  hypertens., cold extremit., Raynauds phenom., CHF or heart block with
                                     with dly.dos. of 30 mg.
       birth/labour, periph.vasc.dis., elderly, ren.dysfunct., peri-op period,   underly. card.dis., paraesthes., hear.loss, bld. disords., imp.sex.funct.,
       grad.withdr.                  Anxiety: 40 mg dly., can be incr.to 40 mg 2-3x dly.  allerg.reacts., skin rash, prurit., metabol.disturbs.affect.gluc.contr.&
                                     Migraine prophylax: 40 mg 2-3xdly.incr.at wkly.interv.up to 160 mg
       Drug interactions: Verapamil, digital.(bradycard. & heart block),   cholester. conc., fluid retent., weight gain, revers. alopec., myopathy.,
       antidiabet., phenothiaz., quinidine & other antiarrhythm.  dly. Max.240 mg/day may be need.by some pts.  stomatit., decr.tear product., blurr.vis.& soren., lupus-like syndr., male
                                     Essent.trem: 40 mg 2-3 x dly.incr.wkly.up to 160 mg dly. Max.320 mg
       INDERAL, AstraZeneca [PWR]    dly. If sympt.of weakness/ faintness occur withdr.temp.& re-start. at   impot., scleros.peritonit., retroperiton.fibros., bronchosp., pneumonit.,
       Propranolol HCl.              low.dose which may be incr.very slowly.  pulm.fibros., pleurisy, periph. neuropathy
       Indications: Ang.pect., essent.& ren.hypertens., essent., senile   Contraindications: React.airway dis.incl.bronch. asthma/bron-  Special-precautions: HF to be control., give only to fully digital.CCF
       & Parkinson trem., anx.relat. autonom. sympts., & anx.tachycard.,   chit./bronchosp/obstruct.airway dis./ CHF/sinoatrial or AV.nodal   pts., gen.anaesth., avoid chloroform & ether, excret.in breast milk, sev.
       card. dysrhythm. esp.supraventr.tachydysrhythm., dysrhythm.trigg.  abnormalit., metabol. acidos/AV block,/sinus bradycard./HF refract.  ren. impairm., clonidine transf., sudd.withdr.poss. exacerb. ang.lead
       by sympathet.over-stimulat., reduc. CV mortal.post MI, thyrotoxi-  to digital/part.sinus heart block/periph.vasc.dis./ Raynaud’s/uraem./  to sudd.death, poss.mask. hyperthyroid.& hypoglycaem.sympts, un-
       cos.& thyrotox. crisis adjunct, hypertroph.obstruct. cardiomyopathy,   lactat.& hypoglycaem., cardiogen. shock., phaeochromocyt.without   mask. myasth. grav., psorias.aggravat., incr.reactiv.to rep. challeng.
       phaeochromocyt., migraine prophylax.  concom. alpha-adrenocept.block.ther., safety in pregn. not est., lac-  with antig.prev.assoc.with anaphylax., elderly, ren./hepat.dysfunct.,
       (S3) TABS, G/5.2/2863.        tat., dos.reduct.in peri-op.per. incr. risk of ang.pect.aggrav./hypertens.,   peri-op.period, concom.digitilisat., grad.withdr., hypoton. newborn
       732567-009: 10 mg, 50, R116,33  aft. prolong. fasting.     inft.if giv.shortly bef.birth/dur.labour, lact.intol.
       Dosage: Take bef.food.        Side effects: GI disturbs., CNS effs., bronchosp., fatig., cold ex-  Drug interactions: Enhanc.hypoglycaem.agents effs., effs.of other
       Ang., hypertens., anx.& essent.trem: Recomm. init.dos: 40 mg   tremit., dry mouth, CV effs., bld. disords., skin rash, prurit., revers.  myocard.depress./phenytoin/ meds interfere.with Ca transport poss.
       2-3xdly. Adeq.respons.in anx.& essent.trem.seen at 80-160 mg/day   alopec., dry mouth, lupus like syndr., male impot., scleros. perotinit.,   enhanc., effs.dimin.by beta-adrenocept.stimulat.agents, hypotens.
       & for ang.& hypertens.at 120-320 mg/day. Further BP reduct.in hy-  retroperiton.fibros., ocul.disords., exacerb./precipit.periph.vasc.dis.,   effs.revers.& periph.vasoconstsrict.effs. enhanc by alpha-adreno-
       pertens.poss.with addit.diuret./antihypertens.  Raynaud’s, impot.,haematolog.reacts.incl. nonthrombocytopen. purp./  cept.stimul., bradycard./ card.arrest & ventric.fibrillat.in pts.receiv.
       Card.dysrhythm., anx.tachycard., hypertroph. obstruct.cardio-  thrombocytopen./ agranulocytos./ trans.eosinoph., floppy inft.syndr.   amiodarone, oral 1 g ampicill.reduc.ser.conc., eff. enhanc.by adren-
       myopathy, thyrotoxicos., migraine prophylax: 10-40 mg 3-4xdly.  (admin. bef./dur.labour)., changes in gluc.contr./ cholesterol conc.  erg.neurone block.agents & diuret., some card.eff.of digital.enhanc.&
       Post MI: Beg.5-21 days aft.MI 180-240 mg dly.in 3 div.dos.   Warnings and special precautions: Not suitab.for emerg.treatm.  others dimin., clear.of disopyramide reduc., incr.periph. vasoconstrict.
       Phaeochromocyt: In conjunction with alpha recept. block. Pre-op.   of hypertens., CCF (pt.fully digital.), clonidine admin., masks sympt.  with ergotam., NSAID’s imp.anti-hypertens.eff.
       60 mg dly x 3 days, malign. cases: 30 mg dly. Elderly: Reduc.dos.  of hyperthyroid./ hypoglycaem., myasth.grav.poss. unmasked., poss.  TENOPRESS, Austell Pharmaceuticals (Pty) Ltd
       Contraindications: Bronchosp., asthma, obstruct. airway.dis.hist.,   psorias.aggravat., elderly/pts. with ren./hepat.dysfunct., grad.dis-  See Section 7.3.3
       bradycard., cardiogen.shock, pres.of hypotens., metabol.acidos., aft.  cont., norm. tachycard.resp.to hypovolaem./bld.loss poss. obscur.
       prolong. fast., sev.periph.arter.circulat.disturbs., 2nd & 3rd degr.heart   dur./aft.surg., sev.react.on repeat.chall.in pts.with hist. of anaphy-  TENORMIN, AstraZeneca [PWR]
       block., sick sinus syndr., untreat. phaeochromocyt., uncontr.HF, Prin-  lact.react.to var.allergens.  Atenolol.
       zmetal’s ang., pts.prone to hypoglycaem., pregn.& lactat.  Drug interactions: Life-threat.conseq.with concom. hypoglycaem.  Indications: Hypertens., ang.pect.
       Side effects: Hypoglycaem.in non diabet.pts., neonates, infts., chil-  agents/phenothiaz./Class 1 antiarrhythm.agents., eff.of concom.  (S3) TABS. 27/5.2/0251, P/5.2/174, J/5.2/120.
       dr., elderly, haemodyalys.pts., concom. anti-diab.ther., prolong.fast.&   myocard. depress. agents (quinidine/procainamide/ lignocaine) en-  797693-009: 25 mg, 30, R162,23
       chron. liv. dis., pts.suffer.from overdos., sev.hypotens., hypoglycaem.,   hanc., eff.dimish.by beta-adrenerg. stimulat.agents, hypotens.eff.   769584-004: 50 mg, 30, R269,96
       fatig., lassit., bradycard., cold extremit., Raynaud’s phenomen., CNS   reversed/periph. vasoconstrict.enhanc.by alpha-adrenerg.stimulat.   769576-001: 100 mg, 30, R438,94
       eff., GI disturbs, dizzin., thrombocytopen., deteriorat.of HF, heart   agents (nor-adren.)/mix.alpha-& ß-adrenerg. stimulants (adrena-  Dosage: Ang.pect: 100 mg dly.or 50 mg 2x dly
       block precipitat., postur.hypotens., exacerbat. intermitt.claudicat.,   line), lidocaine clear.reduc., eff. enhanc.by adrenerg.neurone block.  Hypertens: 50-100 mg sngl.dly.dos. Further BP reduct.poss.with
                                     agents (guanethidine/ bethanidine/reserpine), hypotens. eff. enhanc.
       CCF, purpura, alopec., psoriasiform skin reacts., psorias exacerbat.,   addit.antihypertens.
       skin reacts., paraesthes, dry eyes, vis. disturbs., bronchosp.in bronch.  by diuretics, some card.eff.of digitalis poss. enhanc.& others poss.  Contraindications: Cardiogen.shock, 2nd & 3rd degr.heart block.,
                                     diminish., absorpt. poss. decr.by Al-salts/cholestyramine/colestipol,
       asthma pts./hist of asthmat. complaints, myasthen.grav.-like syndr./   hypotens., metabol.acidos., bradycard., sev.periph.arter.circulat.dis-
       exacerbat. mysthen.grav., sex.impot.  plasma conc.poss.decr.by phenytoin/rifampicin/ phenobarbital, bio-  turbs., untreat. phaeochromocyt., sick sinus syndr., prolong. fast.,
                                     avail.poss incr.by cimetidine/ hydralazine, addit.eff.on card.conduct.
       Special precautions: Phaeochromocyt.start.in pres. of effect.a-  uncontr.HF, revers.obstruct.airways dis.
       block.ther.,peri-op per., poor card. reserve., avoid.in card.fail.unless/  syst.with verapamil/diltiazem, bradycard./card.arrest.& ventric.fi-  Side effects: CCF, bradycard., incr.intermitt. claudicat., cold extremit.,
                                     brillat.with concom.amiodarone, incr. plasma clear.rate with alco-
       until signs of fail. control.with digital./diuret., may aggrav.less sev.   hol, incr.plasma conc./ incr.bio-avail./reduc.metabol.with concom   deteriorat.of HF, heart block, hepat.toxic.incl.intra-hepat.cholestas.,
       periph.arter.circulat.disturbs.& sev.periph.vasc. dis., periph.gangr.pre-  chlorpromazine, bio-avail.incr.with dextropropoxyphene., poss.sev.  postur. hypotens., Raynaud’s, CNS eff., GI disturbs., bld.dyscras., skin
       cipit., 1  degr.heart block pts., may block/modify hypoglycaem.S&S.   rebound hypertens. with clonidine.  reacts., alopec., dry eyes, psorias. exacerbat., paraesthes., bronchosp.
          st
       esp. tachycard., concurr.use of hypoglycaem.ther.in diabet. pts., may   in bronch.asthma pts., vis.disturbs., fatig., impot.
       mask signs of thyrotoxicos.& hypoglycaem., bradycard.less than 55   SANDOZ ATENOLOL 50,100, Sandoz [PWR]  Special precautions: Poor card.reserve., HF to be controll.bef.
       beats/min., pts. with hist.of anaphylact.reacts.may have more sev.   Atenolol  treatm., asthma, bronchit., chron. resp. dis., peri-op period, Prinzmetal
       react.on rep.chall.& be unrespons.to adrenal., port. hypertens.pts.  Indications: Hypertens., ang.pect.  ang., may aggrav. less sev.periph.arter.circulat.disturbs.& sev. pe-
                                                                                 st
       poss.liv.funct.deteriorat.& devel. hepat.encephalopathy, avoid IV   (S3) TABS, X/5.2/388, 389  riph.vasc.dis., precipit.gangrene, 1  degr. heart block pts., may mask
       admin.of Ca chann. block.& propanol. within 48 hrs.of discont. the   787892-009: 50 mg, 30, R25,59  signs of thyrotoxicos., pts. with hist.of anaphylact.reacts.may have
       other, poss.CF in pts.with latent card.insuffic., concom. sympatho-  787914-002: 100 mg, 30, R48,36  more sev.react.on rep.chall.& be unrespons.to adrenaline, lactat.,
       mimet.agents, avoid concom. lignocaine, clonidine transf., discont.  Dosage: Hypertens: 100 mg dly.as sngl.dos.  elderly, hepat./ren.impairm., consid. discont.if inexplic.skin reacts.
       grad., avoid anaesthet. agents caus.myocardial depress., incr. card.   Ang.pect: 50-100 mg dly.as sngl./div.dos.  occur, phaeochromocyt.req. concom.a-adrenerg.block.  ther., masks</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page155.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page151.html">151</a>&nbsp;&nbsp;&nbsp;<a href="page152.html">152</a>&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>&nbsp;&nbsp;&nbsp;<a href="page154.html">154</a>&nbsp;&nbsp;&nbsp;<a href="page155.html">155</a>&nbsp;&nbsp;&nbsp;<a href="page156.html">156</a>&nbsp;&nbsp;&nbsp;<a href="page157.html">157</a>&nbsp;&nbsp;&nbsp;<a href="page158.html">158</a>&nbsp;&nbsp;&nbsp;<a href="page159.html">159</a>&nbsp;&nbsp;&nbsp;<a href="page160.html">160</a>&nbsp;&nbsp;&nbsp;<a href="page161.html">161</a>
             </td>
             <td width="35%"><a href="page157.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page157.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
